Supreme Court to Rule on Access to Key Abortion Pill Mifepristone

The Supreme Court announced Wednesday it will decide this term on the availability of the abortion pill mifepristone, marking the first time the conservative majority high court will rule on reproductive rights since it overturned Roe v. Wade last year.

Both the Biden administration and mifepristone’s manufacturer, Danco Laboratories, had asked the justices to overturn a lower-court ruling from this year that would make obtaining the pill, which is used in more than half of all abortions in the U.S., more difficult.

The U.S. Court of Appeals for the 5th Circuit, based in New Orleans, upheld a portion of a federal judge’s ruling this spring that said the Food and Drug Administration didn’t follow proper procedures when it began loosening regulations for obtaining mifepristone, which has been on the market for two decades since its approval.

Read more at The Daily Beast.